Wael A. Alanazi
King Saud University College of Pharmacy, University of Louisiana at Monroe, King Saud University, Saudi Food and Drug Authority
0000-0002-2761-004X
About
Wael Alanazi earned his Bachelor’s degree in Pharmaceutical Sciences from King Saud University in 2011. After graduation, Wael worked for the Drug Sector at Saudi Food and Drug Authority (SFDA) for evaluation of the quality of pharmaceutical products. In 2012, he worked as a teaching assistant in Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University. In 2013, Wael started his doctoral research in Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, USA. He joined Dr. Jackson’s laboratory and completed his thesis in title “The role of recurrent insulin-induced hypoglycemia on renal prostanoids production, (pro)renin receptor expression and oxidative stress in heart and kidney”. In 2016, Wael earned his Ph.D. in Pharmacology and published several peer-reviewed articles. In 2017, Dr. Wael joined Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University as an assistant professor, and was promoted to associate professor in 2021.
RESEARCH INTERESTS:
• Identify novel therapeutic strategies for prevention of diabetes-induced renal and cardiovascular diseases in various animal models of diabetes.
• Investigate the roles of renin angiotensin system, cyclooxygenases and oxidative stress in diabetic complications.
• Finding the link between blood glucose levels and different vicious pathways causing kidney damage and hypertension in hypoglycemic and/or hyperglycemic animal models.
• Study the antidiabetic activities of new synthetic compounds, and their mechanism of action in glycemic control.
Employment
-
King Saud University College of Pharmacy Associate Professor2021 - Present
-
King Saud University College of Pharmacy The head of the Teaching Load Committee2019 - 2021
-
King Saud University College of Pharmacy The head of the Academic Affairs Committee2019 - 2021
-
King Saud University College of Pharmacy Assistant Professor2017 - 2021
-
University of Louisiana at Monroe Researcher Assistant2013 - 2016
-
King Saud University College of Pharmacy Teaching Assistant2011 - 2017
-
Saudi Food and Drug Authority Drugs Evaluator2011 - 2011
Education
-
University of Louisiana at Monroe Ph.D. in Pharmacology2013 - 2016
-
King Saud University B.S. Pharmaceutical Sciences2006 - 2011
Projects & Funding
Projects & funding information is unavailable.
Publications (36)
- Evaluation of the effects of Tempol on oxidative stress and angiotensin-II induced hypertension in mice exposed to nicotine from electronic and tobacco cigarettes Save
- Cyclic-imide derivative (5e) attenuates hyperglycemia in type 1 diabetic rats by protecting pancreatic cells and enhancing insulin secretion Save
- The Role of Dapagliflozin in the Modulation of Hypothermia and Renal Injury Caused by Septic Shock in Euglycemic and Hyperglycemic Rat Models Save
- Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice Save
- Impacts of the DPP-4 Inhibitor Saxagliptin and SGLT-2 Inhibitor Dapagliflozin on the Gonads of Diabetic Mice Save
- Exposure to Methylmercury at Juvenile Stage Worsens Autism-like Symptoms in Adult BTBR T+tf/J Mice Due to Lack of Nuclear Factor Erythroid 2-Related Factor 2 Signaling Upregulation in Periphery and Brain Save
- Dapagliflozin Mitigates Hypotension in Lipopolysaccharide-Induced Acute Inflammation Independent of Glycemia Level Save
- Mechanism Underlying Triple VEGFR Inhibitor Tivozanib-Induced Hypertension in Mice Model Save
- Effect of Natural Adenylcyclase/cAMP/CREB Signalling Activator Forskolin against Intra-Striatal 6-OHDA-Lesioned Parkinson’s Rats: Preventing Mitochondrial, Motor and Histopathological Defects Save
- Angiotensin II type 1 receptor blockade attenuates gefitinib-induced cardiac hypertrophy via adjusting angiotensin II-mediated oxidative stress and JNK/P38 MAPK pathway in a rat model Save